Skip to main content

Table 1 Two-sample Mendelian randomization results for genetic effect of metformin use on 26 common cancers

From: Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis

Outcomes

IVs amount

Methods

Beta

Odds ratio

OR_lo95%

OR_up95%

P value

Q-statistics

Ph-value

Gastrointestinal tract cancers

Colorectal

24

MR Egger

 − 6.21E+00

2.01E−03

1.43E−07

2.83E+01

2.16E−01

2.88E+01

1.49E−01

Weighted median

 − 2.73E+00

6.53E−02

2.41E−04

1.77E+01

3.40E−01

  

IVW

 − 2.70E+00

6.71E−02

1.27E−03

3.55E+00

1.82E−01

2.97E+01

1.59E−01

Colon

25

MR Egger

6.92E−03

1.01E+00

9.44E−01

1.07E+00

8.36E−01

2.74E+01

2.39E−01

Weighted median

1.18E−02

1.01E+00

9.72E−01

1.05E+00

5.64E−01

  

IVW

1.20E−02

1.01E+00

9.85E−01

1.04E+00

3.86E−01

2.74E+01

2.84E−01

Rectum

9

MR Egger

 − 2.11E−01

8.09E−01

6.33E−01

1.04E+00

1.36E−01

1.04E+01

1.68E−01

Weighted median

 − 1.43E−02

9.86E−01

9.50E−01

1.02E+00

4.49E−01

  

IVW

 − 1.14E−02

9.89E−01

9.56E−01

1.02E+00

5.01E−01

1.42E+01

7.68E−02

Liver

19

MR Egger

6.22E−03

1.01E+00

9.86E−01

1.03E+00

5.59E−01

2.55E+01

8.40E−02

Weighted median

 − 2.30E−03

9.98E−01

9.87E−01

1.01E+00

6.75E−01

  

IVW

 − 3.19E−03

9.97E−01

9.88E−01

1.01E+00

4.70E−01

2.70E+01

7.93E−02

Stomach

24

MR Egger

 − 1.21E+01

5.50E−06

9.34E−14

3.24E+02

1.98E−01

1.31E+01

9.31E−01

Weighted median

 − 4.97E+00

6.97E−03

2.86E−07

1.70E+02

3.35E−01

  

IVW

 − 2.76E+00

6.34E−02

3.68E−05

1.09E+02

4.68E−01

1.43E+01

9.17E−01

Pancreas

24

MR Egger

3.36E+00

2.88E+01

1.23E−08

6.75E+10

7.63E−01

3.03E+01

1.12E−01

Weighted median

5.58E+00

2.64E+02

1.25E−03

5.59E+07

3.73E−01

  

IVW

3.47E+00

3.21E+01

4.92E−03

2.10E+05

4.39E−01

3.03E+01

1.42E−01

Small intestine

25

MR Egger

3.20E−04

1.00E+00

9.84E−01

1.02E+00

9.69E−01

1.96E+01

6.68E−01

Weighted median

3.15E−03

1.00E+00

9.93E−01

1.01E+00

5.58E−01

  

IVW

1.72E−03

1.00E+00

9.95E−01

1.01E+00

6.19E−01

1.96E+01

7.20E−01

Larynx

24

MR Egger

3.50E+00

3.31E+01

1.13E−13

9.68E+15

8.39E−01

2.12E+01

5.10E−01

Weighted median

8.72E+00

6.11E+03

2.23E−06

1.68E+13

4.32E−01

  

IVW

4.62E+00

1.02E+02

9.25E−05

1.11E+08

5.15E−01

2.12E+01

5.70E−01

Oral pharynx

24

MR Egger

 − 1.72E+01

3.26E−08

1.66E−25

6.38E+09

4.05E−01

2.26E+01

4.24E−01

Weighted median

 − 1.16E+01

9.10E−06

1.35E−16

6.11E+05

3.61E−01

  

IVW

 − 1.25E+01

3.86E−06

2.82E−13

5.29E+01

1.37E−01

2.27E+01

4.79E−01

Oesophagus

24

MR Egger

2.15E+01

2.14E+09

4.16E−04

1.10E+22

1.64E−01

2.06E+01

5.46E−01

Weighted median

8.05E+00

3.14E+03

2.61E−05

3.79E+11

3.96E−01

  

IVW

1.15E+01

9.51E+04

4.68E−01

1.93E+10

6.60E−02

2.11E+01

5.73E−01

Breast cancers

Breast cancer

24

MR Egger

6.05E−01

1.83E+00

2.06E−03

1.63E+03

8.63E−01

3.46E+01

4.22E−02

Weighted median

 − 1.10E+00

3.32E−01

1.28E−02

8.65E+00

5.08E−01

  

IVW

 − 2.26E+00

1.05E−01

6.17E−03

1.77E+00

1.18E−01

3.59E+01

4.18E−02

HER(−)

24

MR Egger

3.37E+00

2.91E+01

3.84E−04

2.21E+06

5.62E−01

3.89E+01

1.45E−02

Weighted median

 − 1.33E+00

2.65E−01

1.12E−03

6.27E+01

6.34E−01

  

IVW

 − 2.00E+00

1.36E−01

1.23E−03

1.50E+01

4.06E−01

4.08E+01

1.26E−02

HER(+)

24

MR Egger

 − 1.16E+00

3.14E−01

2.35E−04

4.19E+02

7.55E−01

1.63E+01

7.99E−01

Weighted median

 − 2.42E+00

8.88E−02

1.11E−03

7.09E+00

2.79E−01

  

IVW

 − 4.10E+00

1.66E−02

8.16E−04

3.38E−01

7.66E−03*

1.71E+01

8.04E−01

ER(+)

24

MR Egger

3.59E+00

3.61E+01

1.33E−01

9.78E+03

2.23E−01

1.15E+02

1.68E−14

Weighted median

 − 2.00E−01

8.19E−01

1.18E−01

5.68E+00

8.40E−01

  

IVW

 − 1.19E+00

3.04E−01

2.88E−02

3.22E+00

3.23E−01

1.32E+02

2.88E−17

ER(−)

24

MR Egger

9.72E+00

1.67E+04

1.25E−01

2.22E+09

1.21E−01

3.25E+01

6.90E−02

Weighted median

 − 4.86E+00

7.73E−03

1.87E−05

3.20E+00

1.14E−01

  

IVW

 − 2.73E+00

6.53E−02

4.86E−04

8.78E+00

2.75E−01

3.99E+01

1.56E−02

Lung cancers

Lung

25

MR Egger

 − 5.42E−03

9.95E−01

9.77E−01

1.01E+00

5.52E−01

2.07E+01

5.97E−01

Weighted median

 − 7.87E−03

9.92E−01

9.80E−01

1.00E+00

1.92E−01

  

IVW

 − 6.19E−03

9.94E−01

9.86E−01

1.00E+00

1.06E−01

2.08E+01

6.53E−01

NSCLC

24

MR Egger

 − 2.83E+00

5.88E−02

2.12E−07

1.63E+04

6.62E−01

2.76E+01

0.1910275

Weighted median

 − 7.83E−01

4.57E−01

3.03E−04

6.89E+02

8.34E−01

  

IVW

1.39E−01

1.15E+00

6.62E−03

1.99E+02

9.58E−01

2.79E+01

2.20E−01

SCLC

24

MR Egger

 − 7.91E+00

3.66E−04

1.26E−18

1.06E+11

6.46E−01

1.93E+01

6.29E−01

Weighted median

 − 1.29E+01

2.53E−06

1.97E−15

3.24E+03

2.28E−01

  

IVW

 − 4.91E+00

7.35E−03

6.55E−09

8.25E+03

4.89E−01

1.93E+01

6.84E−01

Skin cancers

Skin

16

MR Egger

 − 1.06E−02

9.89E−01

9.47E−01

1.03E+00

6.47E−01

1.72E+01

2.47E−01

Weighted median

 − 4.75E−03

9.95E−01

9.71E−01

1.02E+00

7.05E−01

  

IVW

3.59E−03

1.00E+00

9.84E−01

1.02E+00

7.10E−01

1.78E+01

2.75E−01

Melanoma

24

MR Egger

4.95E+00

1.42E+02

1.05E−18

1.92E+22

8.36E−01

2.36E+01

3.70E−01

Weighted median

2.38E+01

2.24E+10

1.90E−02

2.65E+22

9.29E−02

  

IVW

5.54E+00

2.56E+02

1.44E−06

4.55E+10

5.67E−01

2.36E+01

4.28E−01

Non-melanoma

24

MR Egger

 − 2.39E+00

9.21E−02

3.71E−05

2.29E+02

5.56E−01

5.65E+01

7.30E−05

Weighted median

 − 4.90E−01

6.12E−01

3.01E−02

1.25E+01

7.50E−01

  

IVW

 − 6.49E−01

5.22E−01

2.10E−02

1.30E+01

6.92E−01

5.71E+01

1.00E−04

Other cancers

Kidney

24

MR Egger

2.75E+00

1.57E+01

8.17E−06

3.01E+07

7.13E−01

1.90E+01

6.45E−01

Weighted median

1.48E+00

4.40E+00

3.98E−04

4.87E+04

7.55E−01

  

IVW

3.07E+00

2.15E+01

5.05E−02

9.11E+03

3.21E−01

1.90E+01

7.00E−01

Bladder

25

MR Egger

1.26E−02

1.01E+00

9.63E−01

1.06E+00

6.29E−01

1.63E+01

8.43E−01

Weighted median

2.67E−02

1.03E+00

9.93E−01

1.06E+00

1.24E−01

  

IVW

1.88E−02

1.02E+00

9.97E−01

1.04E+00

8.65E−02

1.64E+01

8.75E−01

Bone/cartilage

24

MR Egger

 − 1.34E+00

2.61E−01

7.12E−21

9.56E+18

9.54E−01

2.70E+01

2.11E−01

Weighted median

 − 1.95E+00

1.42E−01

3.60E−12

5.58E+09

8.75E−01

  

IVW

 − 1.22E+01

4.84E−06

4.13E−14

5.68E+02

1.97E−01

2.73E+01

2.41E−01

Thyroid gland

24

MR Egger

 − 6.72E+00

1.20E−03

6.00E−10

2.40E+03

3.74E−01

1.89E+01

6.54E−01

Weighted median

4.42E+00

8.33E+01

7.96E−03

8.71E+05

3.49E−01

  

IVW

1.78E+00

5.93E+00

1.40E−02

2.52E+03

5.64E−01

2.05E+01

6.14E−01

Brain

24

MR Egger

6.43E+00

6.20E+02

5.36E−07

7.18E+11

5.52E−01

1.66E+01

7.87E−01

Weighted median

1.63E+00

5.10E+00

2.02E−05

1.29E+06

7.97E−01

  

IVW

2.64E−01

1.30E+00

2.13E−04

7.97E+03

9.53E−01

1.70E+01

8.11E−01

  1. *P value < 0.05; IVW, inverse variance weighted method; OR, odds ratio; OR_lo95%, the lower margin of OR’s 95% confidence interval; OR_up95%, the upper margin of OR’s 95% confidence interval; IVs, instrumental variants; Ph-value, the P value of heterogeneity, heterogeneity existed when Ph-value < 0.05